Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | STAT3 | P40763 | 14/20 | 0.58 |
| ▸ | MEN1 | O00255 | 1/20 | 0.57 |
| ▸ | MAPT | P10636 | 1/20 | 0.57 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.57 |
| ▸ | POLB | P06746 | 1/20 | 0.56 |
| ▸ | CTDSP1 | Q9GZU7 | 1/20 | 0.56 |
| ▸ | ELANE | P08246 | 1/20 | 0.52 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30289923 | 0.83 | STAT3 (0.66) | STAT3MEN1MAPTKMT2APOLB | |
| SCHEMBL20572206 | 0.81 | ELANE (0.65) | STAT3MEN1MAPTKMT2APOLB | |
| SCHEMBL29425898 | 0.81 | ELANE (0.65) | STAT3MEN1MAPTKMT2APOLB | |
| SCHEMBL29896779 | 0.81 | ELANE (0.65) | STAT3MEN1MAPTKMT2APOLB | |
| SCHEMBL29425927 | 0.81 | ELANE (0.65) | STAT3MEN1MAPTKMT2APOLB | |
| SCHEMBL29426006 | 0.80 | STAT3 (0.64) | STAT3MEN1MAPTKMT2APOLB | |
| Lamalbid SCHEMBL9056954 | 0.78 | POLB (0.66) | STAT3MEN1MAPTKMT2APOLB | |
| SCHEMBL31179881 | 0.78 | STAT3 (0.71) | STAT3MEN1MAPTKMT2A | |
| Chlorotuberoside SCHEMBL29425799 | 0.78 | POLB (0.62) | STAT3MEN1MAPTKMT2APOLB | |
| SCHEMBL31179883 | 0.78 | STAT3 (0.72) | STAT3MEN1MAPTKMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-113788869-B | Preparation method of four iridoid glycoside compounds | 深圳市人民医院 | 2023-04-28 | — | — | CN | disclosed |
| EP-3409766-B1 | AN ESTERASE THAT IS CAPABLE OF CONVERTING IRIDOIDS AND SECO-IRIDOIDS | N ZYME BIOTEC GMBH (DE) | 2022-03-09 | — | — | EP | disclosed |